Clinical Trial

Irisin Hormone as a Novel Diagnostic Marker for Detection and Progression of Diabetic Nephrophathy Patients

Name: Irisin Hormone as a Novel Diagnostic Marker for Detection and Progression of Diabetic Nephrophathy Patients — clinical trial record (NCT07435480)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

Study the relation between irisin level and progression of diabetic nephropathy and its early detection.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-02-20.

Trial Details

NCT Number	NCT07435480
Lead Sponsor	Sohag University
Conditions	Diabetic Nephropathies
Enrollment	200 participants
Start Date	2026-04-01
Primary Completion	2027-03-01 (estimated)
Study Completion	2028-03-01 (estimated)
Updated on ClinicalTrials.gov	2026-03-10